Nevro Corp (NVRO)
4.52
+0.16
(+3.67%)
USD |
NYSE |
Nov 22, 16:00
4.515
0.00 (0.00%)
After-Hours: 20:00
Nevro Cash from Investing (Quarterly): -6.435M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -6.435M |
| June 30, 2024 | -9.528M |
| March 31, 2024 | 25.32M |
| December 31, 2023 | -1.113M |
| September 30, 2023 | 7.283M |
| June 30, 2023 | 11.27M |
| March 31, 2023 | -24.65M |
| December 31, 2022 | 0.458M |
| September 30, 2022 | -56.50M |
| June 30, 2022 | 70.27M |
| March 31, 2022 | 50.07M |
| December 31, 2021 | -34.23M |
| September 30, 2021 | -48.18M |
| June 30, 2021 | 233.79M |
| March 31, 2021 | 50.34M |
| December 31, 2020 | -92.11M |
| September 30, 2020 | -170.13M |
| June 30, 2020 | -167.92M |
| March 31, 2020 | 60.29M |
| December 31, 2019 | 7.646M |
| September 30, 2019 | -12.54M |
| June 30, 2019 | 27.88M |
| Date | Value |
|---|---|
| March 31, 2019 | 9.341M |
| December 31, 2018 | 23.70M |
| September 30, 2018 | -14.42M |
| June 30, 2018 | 7.973M |
| March 31, 2018 | -10.82M |
| December 31, 2017 | -1.369M |
| September 30, 2017 | 10.47M |
| June 30, 2017 | 5.591M |
| March 31, 2017 | -10.62M |
| December 31, 2016 | 9.366M |
| September 30, 2016 | -6.914M |
| June 30, 2016 | -125.63M |
| March 31, 2016 | -8.61M |
| December 31, 2015 | 27.73M |
| September 30, 2015 | 57.85M |
| June 30, 2015 | -59.37M |
| March 31, 2015 | 13.45M |
| December 31, 2014 | -132.41M |
| September 30, 2014 | 4.83M |
| June 30, 2014 | 8.455M |
| March 31, 2014 | 11.07M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-170.13M
Minimum
Sep 2020
233.79M
Maximum
Jun 2021
-4.703M
Average
-0.3275M
Median
Cash from Investing (Quarterly) Benchmarks
| Inspire Medical Systems Inc | -102.97M |
| Inari Medical Inc | -34.25M |
| Stereotaxis Inc | 0.098M |
| Electromed Inc | -0.058M |
| Myomo Inc | 2.825M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.732M |
| Cash from Financing (Quarterly) | -0.354M |
| Free Cash Flow | -56.61M |
| Free Cash Flow Per Share (Quarterly) | 0.0043 |
| Free Cash Flow to Equity (Quarterly) | -3.71M |
| Free Cash Flow to Firm (Quarterly) | 4.013M |
| Free Cash Flow Yield | -34.08% |